TRIP (50) VNET (42) SIFY (48) CEVA (30) ⌘ Pro Terminal →

HealthStream Inc. (HSTM) — RQD Stock Rating Cockpit

$33.70 -0.30% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $33.62

HealthStream Inc. (HSTM) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 67/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.6% avg 90D alpha vs SPY) →

ROARABLE C+ • HOLD / WATCH Cap $1.03B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HSTM Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HSTM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, HealthStream Inc. (NASDAQ: HSTM) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $33.70 (-0.30% 1D, market cap $1.03B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, HSTM ranks #140 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HSTM compare to TRIP and VNET in the Technology sector?

▼

Within the Technology sector (Computer Software: Programming Data Processing), HSTM carries a Roarable C+ (67/100 RQD), trailing P/E of 56.4x, gross margin of —, and ROIC of 5.0%. By comparison, TRIP (TripAdvisor Inc.) holds a D grade (50/100 RQD, P/E 27.0x, ROIC 13.0%, cap $1.08B) and VNET (VNET Group Inc.) posts a D- grade (42/100 RQD, P/E N/A, ROIC 85.0%, cap $959.9M). Among the 5-stock peer group, TRIP leads on earnings multiple (27.0x) while VNET leads on capital efficiency (85.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HSTM?

▼

Per HSTM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001095565), HealthStream Inc. generated $304.1M in revenue (+4.3% YoY), $18.3M in net income, and $59.6M in free cash flow against $520.4M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 56x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $33.62 (-0.24%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 19.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 67/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.6% avg 90D alpha vs SPY • 56.4% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HSTM)Realized 20D OHLCV Swing Band: ±5.4%

Deterministic 5-Pillar Attribution (67/100 Composite)

🔍 WHY HSTM SCORES 67/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (22% of score)

20D Institutional Volume Accumulation (±5.4% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+15/20 pts (22% of score)

FRED Regime × Technicals: 88% of 52W Range • RSI-14 at 61 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution11/20 pts (-9 pt drag)

Cannibal Buyback (-0.96% YoY Shares) & executive Form 4 sales trim 9 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$33.46-0.4% Next Q

Q2 (-2Q)

Grade C+$33.31+4.7% Next Q

Q3 (-1Q)

Grade C+$34.86-3.3% Next Q

Current

Grade C+$33.70+1.6% Hist 90D α

Trajectory: C (59) → C+ (67)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HSTM Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 67/100 (C+) score, HSTM faces multiple-compression risk if 56.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 56x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($31.04) or 200D SMA ($25.64) invalidates the momentum regime and cuts Target Base ($35.06) toward Bear Floor ($27.35).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HSTM• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HSTM Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 67%NO 33%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

6130 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCORESOLID CORE (5–6)

5 / 99-Pt Accounting

52-WEEK LASER RANGE88% OF RANGE

L: $20$33.70H: $36

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: CRQD 13 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 26 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B-RQD 28 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on HSTM

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (65)

5.0% ROIC with 42.0% gross margin and 5.77% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (65)

Altman-Z 4.20 and Piotroski 5/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BULLISH (68)

26/40 institutional & smart-money positioning score with 15/20 macro alignment.

Bull Case: Why Buyers Like HSTM

✓Big institutional funds and options desks are actively positioning on the bullish side.

Bear Case: What Could Go Wrong

!Priced at 56x earnings—high expectations leave less room for a lukewarm quarter.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HSTM Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HSTM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +58.59%▲ ASCENDING CHANNEL

2026-11-02O $33.73H $33.80L $33.70C $33.70VOL 129.8K

RES: $36.28SUP: $30.33SMA50: $31.04SMA200: $25.64

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HSTM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HSTM Butterfly Map → + Track HSTM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

39.7%/yr Implied 5Y Growth

vs. +4.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HSTM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HSTM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HSTM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HSTM)

Technology Rank #140 of 714 ⚔️ TRIP vs HSTM Full Matrix →

1. Head-to-Head Technology Peer Comparison (HSTM vs. TRIP, VNET, SIFY, CEVA)

Industry: Computer Software: Programming Data Processing (72 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, HealthStream Inc. (HSTM) ranks #140 by composite RQD confidence (67/100, grade C+) and #350 by equity capitalization ($1.03B). Within this direct 5-issuer industry benchmark cohort, TRIP leads on earnings valuation at 27.0x trailing P/E, while VNET leads on capital efficiency and profitability with 85.0% ROIC and — gross margin. HSTM currently leads its immediate peer cohort in composite quantitative strength at 67/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HSTM ACTIVE HealthStream Inc.	C+	67/100	56.4x	—	5.0%	-0.30%	$1.03B	Benchmark Subject
TRIP TripAdvisor Inc.	D	50/100	27.0x	92.3%	13.0%	0.00%	$1.08B	/trip-vs-hstm →
VNET VNET Group Inc.	D-	42/100	—	—	85.0%	-4.45%	$959.9M	/vnet-vs-hstm →
SIFY Sify Technologies Limited	D	48/100	—	—	—	-1.50%	$914.8M	/sify-vs-hstm →
CEVA CEVA Inc.	E	30/100	—	87.1%	-3.0%	-8.18%	$905.2M	/ceva-vs-hstm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001095565

In its most recent audited fiscal period (FY2025, filed 2025-12-31), HealthStream Inc. (HSTM) reported GAAP revenue of $304.1M (+4.3% vs. FY2024 revenue of $291.6M , and +9.0% cumulative change since FY2023) , GAAP net income of $18.3M, operating cash flow of $63.3M, and free cash flow of $59.6M (+6.0% YoY). On the balance sheet, HSTM closed FY2025 with $520.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$304.1M	$18.3M	$63.3M	$59.6M	$520.4M	—
FY2024 (FY)	2024-12-31	$291.6M	$20.0M	$57.7M	$56.3M	$510.8M	—
FY2023 (FY)	2023-12-31	$279.1M	$15.2M	$64.0M	$64.0M	—	—

3. HSTM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HSTM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does HSTM compare to TRIP and VNET in the Technology sector?

What are the biggest fundamental strengths and SEC risk factors for HSTM?

Where is HSTM trading relative to its 50-day, 200-day, and 52-week technical levels?

HSTM last traded at $33.70 (-0.30% on volume of 151,660 shares), positioning the stock +8.57% above its 50-day simple moving average ($31.04) and +31.44% above its 200-day simple moving average ($25.64). Across its 52-week range of $19.50 to $35.61, HSTM sits at the 88.1% percentile with a 14-day RSI of 61.0 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.4% ($31.88 to $35.52).

HSTM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell HSTM stock right now?

HealthStream Inc. (HSTM) currently earns a Roarable Rating of C+ (Hold — HOLD) with 67/100 RQD Confidence. Solid steady margins (5% return on capital), mixed timing at 56x P/E—hold if owned, no rush to chase.

What is HSTM's 12-month price target and RQD AI Jury consensus?

HSTM's 12-month base price target is $35.06 (range $27.35 to $41.37), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: HSTM RQD Cockpit HSTM 12M Forecast HSTM Earnings & Move HSTM Dividends & DRIP HSTM Insiders & 13F HSTM Whale Options HSTM Profit Sankey HSTM News & Why

ROARABLE RATING BRIEF • RQD 67/100 (C+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

HSTM — HealthStream Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:31:08Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, HSTM scores 67 out of 100, a letter grade of C+, with the verdict "Roarable Hold — Upper Neutral / Watch for Breakout." The five pillars are:

Fundamental Cash Engine (13 / 20): Per the Roarable RQD rating, ROIC is 5% and FCF yield is 5.77%. For a prospective investor, this indicates modest capital efficiency and a cash yield that is moderate relative to the valuation multiples shown in the market data.
Whale 13F Flow (15 / 20): Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. The underlying 13F detail is not present in the holders section (see below), so the pillar score cannot be traced to specific holder data in the source.
Insider Conviction (11 / 20): Per the Roarable RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow. The holders section contains no transaction detail, so the score cannot be traced to specific trades in the source.
Macro Regime Fit (15 / 20): Per the Roarable RQD rating, beta is 1.0 per the market data, indicating market-level sensitivity. The rating cites sector sensitivity without further quantification in the source.
Forensic Balance Sheet (13 / 20): Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. These are mid-range readings and do not indicate distress or strength on their own.

Taken together, the pillar scores suggest a balanced profile with no single dominant strength. Upside drivers cited in the rating are the 15/20 institutional-flow and macro-fit scores; the valuation tradeoff is visible in the market data, where P/E (TTM) is 56.4 and EV/EBITDA is 42.7 against an FCF yield of 5.77%. The rating's "Watch for Breakout" language implies the setup is being monitored rather than actioned. This is educational analysis, not personalized financial advice.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
$33.80	$1.03B	56.4	52.5	42.7	0.6	0.36%	1.0	$19.5 - $35.61	5%

Business

HealthStream Inc. (HSTM) is a NASDAQ-listed issuer classified under the Technology sector and the Computer Software: Programming Data Processing industry. Per the profile, the company operates in this industry with a market capitalization of $1.0B. The source data does not describe its products, customers, or revenue model beyond the sector and industry classification.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$304.1M	$20.2M	$18.3M	N/A	$59.6M	$36.2M	N/A
FY 2024	$291.6M	$21.3M	$20.0M	N/A	$56.3M	$59.5M	N/A
FY 2023	$279.1M	$16.0M	$15.2M	N/A	$64.0M	N/A	N/A

Revenue grew from $279.1M (FY 2023) to $291.6M (FY 2024) to $304.1M (FY 2025), while net income moved from $15.2M to $20.0M to $18.3M. Per the market data, operating margin is 6.7%, net margin is 6%, and gross margin is reported as 0%. Per the Roarable RQD rating, ROIC is 5%, the Altman Z-Score is 2.5, and the Piotroski F-Score is 5/9. Cash declined from $59.5M (FY 2024) to $36.2M (FY 2025), and Debt/Equity is 0.5 per the rating.

Open Questions

What are the specific 13F holders and options positions underlying the 15/20 Whale 13F Flow score, and what is the net direction of institutional change?
What SEC Form 4 and Congressional PTR transactions make up the 11/20 Insider Conviction score?
What is the company's total debt, and what drives the FY 2025 cash decline from $59.5M to $36.2M?
Why is EPS reported as N/A for every period when TTM EPS is listed at 0.6?
What do the reported gross margin of 0% and the company's core products and customers look like in the underlying filings?

HSTM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for HealthStream Inc. (HSTM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HSTM Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 8h ago

HealthStream, Inc. (HSTM) Stock Forecasts

Yahoo Finance report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 11h ago

HealthStream will release third-quarter results after markets close Nov. 2, then discuss them the next morning.

Stock Titan report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH MarketBeat • 14h ago

HealthStream, Inc. $HSTM Stock: Copeland Capital Management LLC Cuts Position

MarketBeat report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Simply Wall St • 17h ago

HealthStream (HSTM) Rallied On Resilient Subscription Revenue But Is The Valuation Already Priced In

Simply Wall St report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 20h ago

Stock award vesting brings HealthStream (HSTM) CTO 895 shares; 218 are withheld for taxes.

Stock Titan report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 23h ago

HealthStream (NASDAQ:HSTM) Stock Bumped Up to "Hold" by Freedom Capital

MarketBeat report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH MarketBeat • 1d ago

HealthStream (NASDAQ:HSTM) Stock Rating Cut to Hold at Wall Street Zen

MarketBeat report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

Director Linda Rebrovick proposes selling 12,000 HealthStream (NASDAQ: HSTM) shares.

Stock Titan report covering HealthStream Inc. (HSTM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HSTM Bull vs. Bear Conversation Board — What's Your Call at $33.70?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HSTM 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $36.50 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is HSTM (C+ • RQD 67/100) a Buy at $33.80?

Welcome to the HSTM (HealthStream Inc.) Roar Pit. Current RQD Composite is 67/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Computer Software: Programming Data Processing. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (56.4x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $27.38 (-19.0%)

Spot @ $33.80

Pump the brakes on HSTM — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on HSTM, but look at what you are paying: 56.4x trailing P/E with tightening sector spreads. Unless HealthStream Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader 🐂 BULLISH 🎯 Target: $41.24 (+22.0%)

Spot @ $33.80

HSTM cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on HSTM, the market is fixating on short-term headline noise in Computer Software: Programming Data Processing and ignoring the balance sheet and cash flow trajectory. At $33.80 (52-wk range $19.50 - $35.61), any beat on forward guidance forces shorts and underweight funds to chase.